Sign In to Follow Application
View All Documents & Correspondence

Process For The Preparation Of Spiro [Cis 4 (β Hydroxyethyloxy)cyclohexane [3 H]Indol] 2'[1'h]One Derivatives

Abstract: PROCESS FOR THE PREPARATION OF SPIRO-[CIS-4-(β-HYDROXYETHYLOXY)CYCLOHEXANE-[3H]INDOL]-2'[1'H]ONE DERIVATIVES

Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence

Patent Information

Application #
Filing Date
20 December 2001
Publication Number
22
Publication Type
INA
Invention Field
CHEMICAL
Status
Email
Parent Application
Patent Number
Legal Status
Grant Date
2006-11-02
Renewal Date

Applicants

SANOFI-SYNTHELABO
OF 174 AVENUE DE FRANCE, F-75013 PARIS, FRANCE.

Inventors

1. 1) GERGELY HEJA, 2) CSABA GONCZI
OF 174 AVENUE DE FRANCE, F-75013 PARIS, FRANCE.

Specification

FORM 2
THE PATENTS ACT 1970
[39 OF 1970]
COMPLETE SPECIFICATION
[See Section 101 RULE 13]
"PROCESS FOR THE PREPARATION OF SPIRO-[cis-4-(β-HYDROXYETHYLOXY)CYCLOHEXANE-[3H]INDOL]-2'[ 1'H]ONE DERIVATIVES"
SANOFI-SYNTHELABO, of 174, Avenue de France, F-75013 Paris, France,

The following specification particularly describes the nature of the invention and the manner in which it is to be performed:-

The subject of the present invention is a process for the preparation of spiro[cis-4-(p-hydroxyethyloxy)cyclohexane-[3H]indol]-2'[1 'H]-one derivatives of general formula I.

The spiro[cis-4-(β-hydroxyethyloxy)cyclohexane-1,3'-(5'-ethoxy)-[3.H]indol]-2'[l'H]-one is an important intermediate to the vasopressin V2 antagonistic agent, SR 121463. Preparation of the latter compound and its intermediate of formula I are described in patent application of WO 9715556.
According to the process described in the above patent application, the compounds of general formula I are prepared from the compounds of general formula II

using zinc borohydride reducing agent in the presence of
chlorotrimethylsilane in the mixture of dichloromethane and diethyl
ether. By this method the desired cis-isomer is

Obtained in 50-54% yield. The reaction time is long, approximately 20 hours, the zinc
borohydride reagent has to be prepared in situ (it also takes approximately 20 hours)

and the diethyl ether can not be substituted by an other solvent.
Surprisingly, we have found that the reaction can be accomplished under more simple conditions.
The subject of our invention is a process for the preparation of spiro[cis-4-(β-hydroxyethyloxy)cyclohexane-[3H]indo]]-2'[l ,H]-one derivatives of the formula I,

- wherein
R1 and R2 stand independently from each other for hydrogen, C1-4alkyL
C1-4alkoxy, C1-4alkylthio, C1-4polyfluoroalkyl, C1-4polyfluoroalkoxy,
C3-7 cycloalkyloxy, C3-7 cycloalkylthio, phenoxy, benzyloxy or nitro group -
by reduction of a dispiro[(l,3-dioxolane)-2,4'-cyclohexane-1,3"-[3H]indol]-
2"[1 "H]-one derivative of the general formula II,

wherein R1 and R2 are as defined above, which comprises carrying out the reduction a) with sodium cyanoborohydride in the presence of a Lewis acid, or
r
b) with sodium borohydride in the presence of a strong acid.

Redueing agents sodium cyanoborohydride and sodium borohydride are available from the market.
In the process according to the present invention as for Lewis acid aluminum chloride, zinc chloride, iron/Ill/ chloride, preferably boron trifluoride etherate; as for strong organic acid trifiuoroacetic acid, dichloro acetic acid, methanesulfonic acid, trifluoromethanesulfohic acid, preferably trichloroacetic acid can be used.
A further advantage of the process of the present invention is that the use of diethyl ether as solvent can be eliminated, as for solvents, halogenated hydrocarbons, preferably dichloromethane can be applied.
By the method according to the present invention the pure cis-isomer can be obtained by 67-75% yield.
Further details of the invention are demonstrated by the following examples, without limiting the claims to the examples.

Examples
l.)In the solution made of 121,3 g of dispiro[(l,3-dioxolane)-2,4' cyclohexane-l'J3"-(5"-ethoxy)-[3H]indol]-2"[1"H]-one in 1000 ml of dichloromethane, under inert atmosphere 37,2 g of sodium cyanoborohydride is added, then dropwise, at -5 °C 170,3 g of borontrifluoride etherate. The reaction mixture is then allowed to warm up to room temperature (approx. 45 minutes) and stirred at that temperature for 1,5 hours. To the diluted suspension 500 ml of 10% sodium hydroxide solution is dropped and after 30 minutes of stirring dichloromethane is distilled off. After cooling back to room temperature, to the aqueous mixture, slowly, 500 ml of ethanol is added, and the mixture is then stirred and heated at reflux temperature for 1 hour. Ethanol is distilled off in vacuum, the residue is diluted with 300 ml of water, extracted with 4 x 100 ml of dichloromethane, washed with 2 x 250 ml of water, dried with sodium sulfate and evaporated. The residual brown oil is dissolved under reflux in 350 ml of toluene, clarified with active carbon and filtered. The precipitating crystals are filtered off. The resulting 100,6 g (82 %) product is recrystallized from 300 ml of toluene. Thus, 91 g product of appropriate purity is obtained. Yield: 74,5 %. Ratio of the isomers (HPLC): cis: 95,5%; trans 1,8%.
2.) 9.1g of dispiro[(l,3-dioxolane)-2,4'-cyclohexane-1',3",-(5"-ethoxy)-[3H]indol]-
2"[1"H]-one is dissolved in 100 ml of dichloromethane, to the solution 3,4 g of
sodium borohydride and 0,6 g of ben2yitriethylarnmonium chloride is added. To the'
mixture at room temperature , in a period of 1 hour, the solution of 29,4 g of
trichloroacetic acid in 50 ml of dichloromethane is added. The mixture is stirred for an
additional hour, then 130 ml of 1 N sodium hydroxide solution is added to it. After 30
minutes of stirring the ethanol is distilled off in vacuum, the residue is diluted with 100
ml of water and extracted with dichloromethane. The organic phase is evaporated, the
oily residue is crystallized from 50 ml of toluene. Thus, 6,25 g of product is obtained,
mp.: 123-124 °C. Yield: 68 %.
Ratio of the isomers (HPLC): cis 98,7%, trans 1%.



WE CLAIMS

1.) Process for the preparation of spiro[cis-4-(β-hyclroxyethyloxy)cyclohexane-[3H]indol]-2'[1'H]-one derivatives of the formula I,

- wherein
R1 and R2 stand independently from each other for hydrogen, C1-4alkyl,
C1-4alkoxys C1-4alkylthio, C1-4polyfluoroalkyl, C1-4polyfiuoroalkoxy,
C3-7cycloalkyIoxy, C3-7 cycloalkylthio, phenoxy, benzyloxy or nitro group -
by reduction of a dispiro[(1,3-dioxolane)-2,4'-cyclohexane-1,3"-[3H]indol]-
2"[1 "H]-one derivative of the general formula II,

1 2
wherein R and R are as defined above, which comprises carrying out the reduction a.) with sodium cyanoborohydride in the presence of a Lewis acid, or b) with sodium borohydride in the presence of a strong acid.
2.) Process according to claim 1, which comprises using as Lewis acid aluminum chloride, zinc chloride, iron/Ill/ chloride, preferably boron trifiuoride etherate. .

3) Process according to claim 1, which comprises using as strong organic acid trifluoroacetic acid, dichloro acetic acid, methanesulfonic acid, trifluoromethanesulfonic acid, preferably trichloroacetic acid.
4.) Process according to claim 1, which comprises using as solvent haiogenated hydrocarbons, preferably dichloromethane.
Dated this 20th day of December,2001.


[SANJAY KUMAR]
OF REMFRY&SAGAR
ATTORNEY/FOR THE APPLICANTS

Documents

Application Documents

# Name Date
1 in-pct-2001-01626-mum-form-pct-isa-210(20-12-2001).pdf 2001-12-20
2 in-pct-2001-01626-mum-form-pct-ipea-409(20-12-2001).pdf 2001-12-20
3 in-pct-2001-01626-mum-form 5(20-12-2001).pdf 2001-12-20
4 in-pct-2001-01626-mum-form 3(20-12-2001).pdf 2001-12-20
5 in-pct-2001-01626-mum-form 3(23-10-2004).pdf 2004-10-23
6 in-pct-2001-01626-mum-form 1(23-10-2004).pdf 2004-10-23
7 in-pct-2001-01626-mum-power of authority(27-10-2004).pdf 2004-10-27
8 in-pct-2001-01626-mum-petition under rule137(27-10-2004).pdf 2004-10-27
9 in-pct-2001-01626-mum-form 2(granted)-(27-10-2004).pdf 2004-10-27
11 in-pct-2001-01626-mum-drawing(27-10-2004).pdf 2004-10-27
12 in-pct-2001-01626-mum-claims(granted)-(27-10-2004).pdf 2004-10-27
14 in-pct-2001-01626-mum-cancelled page(27-10-2004).pdf 2004-10-27
15 in-pct-2001-01626-mum-abstract-(27-10-2004).pdf 2004-10-27
17 in-pct-2001-01626-mum-correspondence(ipo)-(29-12-2004).pdf 2004-12-29
18 in-pct-2001-01626-mum-correspondence(24-10-2007).pdf 2007-10-24
19 in-pct-2001-01626-mum-power of authority(3-9-2007).pdf 2018-08-08
20 in-pct-2001-01626-mum-petition under rule137(14-6-2005).pdf 2018-08-08
21 in-pct-2001-01626-mum-form 19(6-11-2003).pdf 2018-08-08
22 in-pct-2001-01626-mum-correspondence(ipo)-(5-8-2011).pdf 2018-08-08
23 abstract1.jpg 2018-08-08

ERegister / Renewals

3rd: 12 Feb 2007

From 13/07/2002 - To 13/07/2003

4th: 12 Feb 2007

From 13/07/2003 - To 13/07/2004

5th: 12 Feb 2007

From 13/07/2004 - To 13/07/2005

6th: 12 Feb 2007

From 13/07/2005 - To 13/07/2006

7th: 12 Feb 2007

From 13/07/2006 - To 13/07/2007

8th: 12 Sep 2007

From 13/07/2007 - To 13/07/2008

9th: 27 Jun 2008

From 13/07/2008 - To 13/07/2009

10th: 30 Jun 2009

From 13/07/2009 - To 13/07/2010

11th: 24 Jun 2010

From 13/07/2010 - To 13/07/2011